NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
AlzeCure Pharma AB (publ) (ST: ALZCUR)
ALZCUR Technical Analysis
5
As on 23rd Dec 2024 ALZCUR STOCK Price closed @ 1.19 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.28 & Strong Sell for SHORT-TERM with Stoploss of 4.55 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ALZCURSTOCK Price
Open | 1.27 | Change | Price | % |
High | 1.27 | 1 Day | -0.07 | -5.56 |
Low | 1.15 | 1 Week | -0.02 | -1.65 |
Close | 1.19 | 1 Month | -0.43 | -26.54 |
Volume | 47078 | 1 Year | -4.15 | -77.72 |
52 Week High 5.34 | 52 Week Low 1.00 |
ST Sweden Most Active Stocks
FING-B | 0.03 | 0.00% |
SBB-B | 4.33 | 5.61% |
WYLD | 0.01 | 0.00% |
LUNE | 21.97 | 6.65% |
STRAX | 0.14 | 16.67% |
ACTI | 0.11 | 0.00% |
EPIS-B | 0.12 | 0.00% |
FLUI | 0.03 | -25.00% |
ENERS | 0.01 | % |
QUIA | 0.01 | -50.00% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
ALZCUR Daily Charts |
ALZCUR Intraday Charts |
Whats New @ Bazaartrend |
ALZCUR Free Analysis |
|
ALZCUR Important Levels Intraday
RESISTANCE | 1.42 |
RESISTANCE | 1.35 |
RESISTANCE | 1.30 |
RESISTANCE | 1.26 |
SUPPORT | 1.12 |
SUPPORT | 1.08 |
SUPPORT | 1.03 |
SUPPORT | 0.96 |
ALZCUR Forecast December 2024
4th UP Forecast | 4.85 |
3rd UP Forecast | 3.68 |
2nd UP Forecast | 2.95 |
1st UP Forecast | 2.23 |
1st DOWN Forecast | 0.15 |
2nd DOWN Forecast | -0.57 |
3rd DOWN Forecast | -1.3 |
4th DOWN Forecast | -2.47 |
ALZCUR Weekly Forecast
4th UP Forecast | 2.31 |
3rd UP Forecast | 1.95 |
2nd UP Forecast | 1.73 |
1st UP Forecast | 1.51 |
1st DOWN Forecast | 0.87 |
2nd DOWN Forecast | 0.65 |
3rd DOWN Forecast | 0.43 |
4th DOWN Forecast | 0.07 |
ALZCUR Forecast2024
4th UP Forecast | 9.75 |
3rd UP Forecast | 7 |
2nd UP Forecast | 5.31 |
1st UP Forecast | 3.61 |
1st DOWN Forecast | -1.23 |
2nd DOWN Forecast | -2.93 |
3rd DOWN Forecast | -4.62 |
4th DOWN Forecast | -7.37 |
AlzeCure Pharma AB (publ) ( ST Sweden Symbol : ALZCUR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ALZCUR Other Details
Segment | EQ | |
Market Capital | 275689632.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
ALZCUR Address
ALZCUR Latest News
ALZCUR Business Profile
AlzeCure Pharma AB (publ), a pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is developing drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its pipeline drug candidates include ACD856, which is in phase I clinical trial for sleep disorders, traumatic brain injuries, and Alzheimer's disease; ACD857, ACD679, and ACD680 for Alzheimer's disease; ACD440, a VR1 antagonist that is in phase I clinical trial for neuropathic pain; and TrkA-NAM for osteoarthritic pain. The company was founded in 2012 and is based in Huddinge, Sweden. Address: HAelsovAegen 7, Huddinge, Sweden, 141 57
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service